EUVIMEDEUVIMED entdecken
Crossref

The therapeutic antibody sacituzumab induces trophoblast cell-surface antigen-2 conformational rearrangement

Ryan Ferrao, Jinjin Zhang, Chih-Chien Chou, Anthony Nieto, Derek Langeslay, Moon Chatterjee, Debi Jin, Magdeleine Hung, Ian Scott, Mark Nagel, Weimei Xing, Simon Letarte und 3 weitere

Structure · 2026

DOI: 10.1016/j.str.2025.11.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Structure, 2026. Verfasst von Ryan Ferrao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Gilead Sciences Inc., Structural Biology and Chemistry, 333 Lakeside Dr., Foster City, CA 94404, USA. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Antibodies, Monoclonal, Humanized, Cell Adhesion Molecules, Camptothecin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Institutes of Health, National Institute of General Medical Sciences, Howard Hughes Medical Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sacituzumab govitecan (SG) is a therapeutic antibody-drug conjugate globally approved for the treatment of breast cancer. SG targets the trophoblast cell-surface antigen-2 (Trop2) at the surface of cancer cells to deliver the cytotoxic topoisomerase I inhibitor SN-38 to the tumor microenvironment. SN-38 is covalently linked to the humanized monoclonal antibody (mAb) sacituzumab via a hydrolyzable linker. Here, we describe the 1.56-Å X-ray crystal structure and stoichiometry of the human Trop2 ectodomain in complex with a sacituzumab (hRS7) antigen-binding Fab fragment. The complex reveals a 2:2 stoichiometry where two sacituzumab Fabs bind across the two Trop2 dimer subunits, inducing a conformational change compared to the apo-structure. Cryo-electron microscopy (cryoEM) and size-exclusion chromatography in combination with multi-angle light scattering (SEC-MALS) analysis of the intact sacituzumab mAb bound to the Trop2 ECD reveals a complex whereby sacituzumab engages two Trop2 dimers in a 2:4 stoichiometry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, NeoplasmAntibodies, Monoclonal, HumanizedCell Adhesion MoleculesCamptothecinImmunoconjugatesHumansImmunoglobulin Fab FragmentsCrystallography, X-RayCryoelectron MicroscopyModels, MolecularProtein BindingProtein ConformationIrinotecan

Stichwörter der Autor:innen

hRS7regulated intramembrane proteolysissacituzumab govitecantriple-negative breast cancertrophoblast cell-surface antigen-2

Substanzen

Antigens, NeoplasmTACSTD2 protein, humanAntibodies, Monoclonal, HumanizedImmunoglobulin Fab Fragmentssacituzumab govitecanCell Adhesion MoleculesCamptothecinImmunoconjugatesIrinotecan

Autor:innen und Institutionen

  • Gilead Sciences Inc., Structural Biology and Chemistry, 333 Lakeside Dr., Foster City, CA 94404, USA.
  • Gilead Sciences Inc., Protein Therapeutics, 333 Lakeside Dr., Foster City, CA 94404, USA.
  • Gilead Sciences Inc., Oncology, 333 Lakeside Dr., Foster City, CA 94404, USA.
  • Gilead Sciences Inc., Biologics Analytical Operations, 4010 Ocean Ranch Blvd., Oceanside, CA 92056, USA.
  • Gilead Sciences Inc., Biologics Analytical Operations, 4010 Ocean Ranch Blvd., Oceanside, CA 92056, USA. Electronic address: alexandre.ambrogelly@gilead.com.
  • Gilead Sciences Inc., Structural Biology and Chemistry, 333 Lakeside Dr., Foster City, CA 94404, USA. Electronic address: eric.lansdon@gilead.com.

Förderung

  • National Institutes of Health
  • National Institute of General Medical Sciences
  • Howard Hughes Medical Institute
  • Office of Science

Zitieren

APA

Ferrao, R., Zhang, J., Chou, C. C., Nieto, A., Langeslay, D., Chatterjee, M., Jin, D., Hung, M., Scott, I., Nagel, M., Xing, W., Letarte, S., Wang, J., Ambrogelly, A., & Lansdon, E. B. (2026). The therapeutic antibody sacituzumab induces trophoblast cell-surface antigen-2 conformational rearrangement. Structure. https://doi.org/10.1016/j.str.2025.11.002

Vancouver

Ferrao R, Zhang J, Chou CC, Nieto A, Langeslay D, Chatterjee M, et al. The therapeutic antibody sacituzumab induces trophoblast cell-surface antigen-2 conformational rearrangement. Structure. 2026. doi:10.1016/j.str.2025.11.002

BibTeX
@article{Ferrao2026,
  author = {Ferrao, Ryan and Zhang, Jinjin and Chou, Chih-Chien and Nieto, Anthony and Langeslay, Derek and Chatterjee, Moon and Jin, Debi and Hung, Magdeleine and Scott, Ian and Nagel, Mark and Xing, Weimei and Letarte, Simon and Wang, Jenny and Ambrogelly, Alexandre and Lansdon, Eric B},
  title = {The therapeutic antibody sacituzumab induces trophoblast cell-surface antigen-2 conformational rearrangement},
  journal = {Structure},
  year = {2026},
  doi = {10.1016/j.str.2025.11.002}
}
Kostenlos starten →